Not impressedThis Company has always had problems, if it's not delays then it's cheap under the table financings or disgusting Directors pay increases . We need to be a Company based on performance , not one that continually succumbes to never ending problems. PMN 310 has been talked about for years and now when they get FDA approval they are stalled. Poor financial decisions by this board.